|
|
 |
|
Viewing report
|
|
 |
 |
Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application - 2 Volume Set
John Wiley and Sons Ltd, March 2007, Pages: 1,260
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Anxiety Disorders - Viable Indication for Antipsychotics Companies
CNS Drug Discoveries: Schizophrenia Chapter
Anxiety, Phobias & Panic Disorders - 2009 Edition
Are There Changes Ahead for the Generalized Anxiety Disorder Market?
Anxiety Disorders - A Decade of Declining Revenues
Pipeline Insight: Schizophrenia
Strategic Perspectives 2001: Generalized Anxiety Disorder - Driven by Effexor and Open to Expansion
Stakeholder Insight: Anxiety Disorders - More Than Just a Comorbidity
Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression
Pipeline and Commercial Insight: Schizophrenia - Second Generation Depots Protect Market Value
Dopamine Transporters : Chemistry, Biology, and Pharmacology
Neuroprotection - Drugs, Markets and Companies
|
 |
|
|